Novi Arie Anggraeni

Name   : Novi Arie Anggraeni
Batch : 2022
E-mail   : noviarieanggraeni@gmail.com
Interest : Molecular biology, microbiology, medical biotechnology, recombinant protein

Research Experience
My thesis project focused on developing a recombinant ACE2-like enzyme as a potential drug candidate for acute lung injury due to SARS-CoV-2. This candidate is expected to be safe and effective. The study successfully confirmed the purified enzyme through affinity chromatography and demonstrated its activity against the native substrate using the LCMS approach. Furthermore, the recombinant enzyme proved to be twice as effective as the control in inhibiting the SARS-CoV-2 spike protein and showed no toxicity to Vero E6 cells.

Skills
Bacterial cultivation and assay, nucleic acid extraction, PCR, gel electrophoresis, recombinant protein technology, SDS-PAGE, Western blot, ELISA, basic HPLC and LCMS analysis, basic animal cell culture, MTT assay.

Testimonial
The Biotechnology Master’s Program at the School of Life Sciences and Technology, ITB, provides an excellent learning environment, particularly for those pursuing advanced molecular research. The program’s curriculum is comprehensive and up-to-date, providing students with in-depth knowledge and hands-on experience in cutting-edge molecular biology techniques. The faculty members are experts in their areas of specialization, particularly in the field of molecular biology, and are highly supportive in guiding students through complex research challenges. Their expertise, coupled with access to state-of-the-art facilities, makes the program an optimal platform for students to advance their skills and make significant contributions to molecular research. This program has been instrumental in shaping my career in biotechnology, equipping me with both theoretical insights and practical experience that are essential for success in this rapidly evolving field.